More grim new from the Ministry of Health: EBOLA DRC - Evolution of the response to the Ebola outbreak in the provinces of North Kivu and Ituri to Sunday, April 28, 2019. Excerpt from the Google translation:
EPIDEMIOLOGICAL SITUATION IN THE PROVINCES OF NORTH KIVU AND ITURI
Sunday, April 28, 2019
The epidemiological situation of the Ebola Virus Disease dated April 27, 2019:
• Since the beginning of the epidemic, the cumulative number of cases is 1,439, of which 1,373 are confirmed and 66 are probable. In total, there were 931 deaths (865 confirmed and 66 probable) and 410 people healed.
• 263 suspected cases under investigation;
• 22 new confirmed cases, including 6 in Butembo, 4 in Katwa, 4 in Mabalako, 3 in Mandima, 3 in Kalunguta, 1 in Beni and 1 in Musienene;
• 17 new confirmed deaths, including
º 10 community / hospital deaths including 3 in Kalunguta, 2 in Katwa, 2 in Mandima, 1 in Butembo, 1 in Musienene and 1 in Mabalako;
º 7 deaths at CTE, including 4 in Butembo and 3 in Katwa;
• 5 new cures from the Butembo CTE;
UPDATE: Three health workers were among the new confirmed cases in the last two weeks, including 1 (deceased) reported in the Ebola report of 19 April 2019 and 2 reported in the bulletin of 26 April 2019. The cumulative number of confirmed cases / probable among health workers is 92 (6.39% of all confirmed / probable cases) including 33 deaths.
/! \ The data presented in this table is subject to further changes after thorough investigation and after redistribution of cases and deaths in their health areas.
News of the response
Vaccination
• Since the start of vaccination on August 8, 2018, 106,904 persons have been vaccinated , including 28,599 in Katwa, 23,037 in Beni, 13,116 in Butembo, 6,904 in Mabalako, 4,831 in Mandima, 3,236 in Kalunguta, 3,070 in Goma, 2,729 in Oicha, 2,699 to Komanda, 1,889 to Masereka, 1,875 to Vuhovi, 1,718 to Kyondo, 1,630 to Kayina, 1,487 to Bunia, 1,357 to Karisimbi, 1,313 to Lubero, 1,047 to Musienene, 1,025 to Biena, 772 to Mutwanga, 690 to Rutshuru, 557 in Rwampara (Ituri), 527 in Nyankunde, 496 in Mangurujipa, 420 in Mambasa, 355 in Tchomia, 342 in Kirotshe, 333 in Lolwa, 254 in Alimbongo, 250 in Mweso, 245 in Kibirizi, 161 in Nyiragongo, 97 in Watsa (Haut-Uélé) and 13 in Kisangani.
• The only vaccine to be used in this outbreak is the rVSV-ZEBOV vaccine, manufactured by the pharmaceutical group Merck, following approval by the Ethics Committee in its decision of 19 May 2018.
